European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)
According to the experts behind the review, atherosclerotic Cardiovascular Disease remains the leading cause of premature death worldwide. CVD affects both men and women: of all deaths that occur before age 75 in Europe, 42% are due to CVD in women and 38% in men.
Prevention works: over 50% of the reductions seen in coronary heart disease mortality relate to changes in risk factors, and 40% to improved treatments. This is a lifelong endeavour – we should begin efforts to prevent CVD from birth – if not before.
European experts in cardiovascular medicine have released an important update to their guidelines on preventing cardiovascular disease – the leading cause of premature death worldwide.
In these new guidelines, healthcare providers will find answers to key questions including:
- What is CVD prevention?
- Why is it needed?
- Who should benefit from it?
- How can CVD prevention be applied?
- When is the right moment to act?
- Where should prevention programmes be provided?
SAGE is to sponsor the panel discussion chaired by Professors Joep Perk and David Wood, on the new 2012 Joint European Societies’ Guidelines on cardiovascular disease, at the two day symposium to address the national agenda on cardiovascular disease prevention, held at Imperial College London.
Richard Hobbs, Arno Hoes, Sehnaz Karadeniz, Alessandro Mezzani, Eva Prescott, Lars Ryden, Martin Scherer, Mikko, Pascale Benlian, Gudrun Boysen, Renata Cifkova, Christi Deaton, Shah Ebrahim, Miles Fisher, Giuseppe Germano,, & Joep Perk, Guy De Backer, Helmut Gohlke, Ian Graham, Zeljko Reiner, WM Monique Verschuren, Christian Albus, Syvänne, Wilma JM Scholte Op Reimer, Christiaan Vrints, David Wood, Jose Luis Zamorano and Faiez Zannad (2012). European Guidelines on cardiovascular disease prevention in clinical practice (version 2012) European Journal of Preventive Cardiology , 10 (4) : 10.1177/2047487312450228